Validation of a genomic classifier that predicts metastatic disease progression in men with biochemical recurrence post radical prostatectomy.

作者
Ashley Evan Ross,Mercedeh Ghadessi,Elai Davicioni,Anamaria Crisan,Christine Buerki,Nicholas Erho,Anirban Pradip Mitra,Darby J. S. Thompson,Timothy Junius Triche,Felix Yi-Chung Feng,Edward Matthew Schaeffer
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:31 (15_suppl): 5033-5033 被引量:1
标识
DOI:10.1200/jco.2013.31.15_suppl.5033
摘要

5033 Background: Almost 50,000 men per year will present with biochemical recurrence (BCR) following local treatment for prostate cancer. These men with rising PSAs as the lone indicator of recurrence present a management dilemma due to their varied outcomes with only a proportion developing subsequent metastatic disease. Thus, there is a clear need to improve patient risk stratification in this context. Here, we evaluate Decipher, a genomic classifier (GC) in men with BCR following radical prostatectomy (RP) for its ability to predict metastasis. Methods: The 22-marker GC was validated in a prospectively designed case-cohort study of 1,010 clinically high-risk RP patients. 219 patients, including 85 who developed BCR at least 6 months post-RP were subjected to microarray analysis and GC scores were generated. Survival ROC curves, weighted Cox proportional hazards, and decision curves were used to compare the performance of the GC to Gleason score (GS), PSA doubling time (PSAdT) and time to BCR (ttBCR). Results: GC scores significantly stratified these men into those who would or would not develop metastasis after BCR (8% versus 40% of patients developed metastasis at 3 years following BCR depending on GC score category, p<0.001). The AUC for GC was 0.82 (95% CI, 0.76-0.86), compared to that of GS 0.64 (0.58-0.70), PSAdT 0.69 (0.61-0.77) and ttBCR 0.52 (0.46-0.59). In decision curve analysis, the GC had the highest overall ‘net benefit’ and in multivariable modeling with clinicopathologic variables, only GC (p=0.006) and GS (p=0.046) scores were significant predictors of metastasis. Conclusions: When compared to clinicopathologic variables, the GC better predicted metastatic progression among men with BCR following RP. While confirmatory studies in additional patient populations are required, these results suggest that use of the GC can allow for better selection of men requiring additional treatment at the time of BCR.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
1秒前
GamAooL发布了新的文献求助10
2秒前
2秒前
啦啦啦完成签到 ,获得积分10
3秒前
Iriss完成签到 ,获得积分10
3秒前
3秒前
行走的荷尔蒙的应助被依山尽采纳,获得30
4秒前
ZYP完成签到,获得积分10
4秒前
科目三的应助被小棕瓶采纳,获得10
4秒前
revo完成签到,获得积分10
5秒前
温暖大米完成签到,获得积分20
5秒前
酷炫的金鱼完成签到 ,获得积分10
5秒前
喜悦的聪展完成签到 ,获得积分10
5秒前
典雅碧空发布了新的文献求助10
6秒前
慕青的应助被Lily采纳,获得10
6秒前
天真的乌龟完成签到 ,获得积分10
6秒前
12发布了新的文献求助10
7秒前
syvshc的应助被chenlina采纳,获得10
7秒前
7秒前
7秒前
美丽冬卉发布了新的文献求助10
7秒前
DW的应助被雪白玉米采纳,获得10
8秒前
lm发布了新的文献求助10
8秒前
Maestro_S的应助被tang采纳,获得100
9秒前
细腻谷南完成签到,获得积分10
9秒前
完美世界的应助被zzz采纳,获得10
9秒前
9秒前
学霸颖发布了新的文献求助10
10秒前
11秒前
cora发布了新的文献求助10
11秒前
夜雨完成签到 ,获得积分10
11秒前
12秒前
荼蘼发布了新的文献求助10
12秒前
13秒前
crescendo完成签到,获得积分10
14秒前
14秒前
14秒前
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175262
求助须知:如何正确求助?哪些是违规求助? 9567017
关于积分的说明 21789663
捐赠科研通 7769695
什么是DOI,文献DOI怎么找? 3431840
关于科研通互助平台的介绍 2556124
邀请新用户注册赠送积分活动 2477241